Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardioprotective ginkgolides under study at CNRS

Nov. 16, 1999

Favorable phase II results announced for Valentis's VEGF165 gene medicine at AHA

Nov. 15, 1999

Mechanism of antioxidant action of S-17834 explored in vitro

Nov. 15, 1999

AstraZeneca's immunomodulator H-327/86 is a novel candidate for treating atherosclerosis

Nov. 15, 1999

United Therapeutics completes enrollment in phase III pulmonary hypertension trial

Nov. 12, 1999

Synergistic effects Na+/H+ exchange inhibitor and K(ATP) channel opener in MI

Nov. 11, 1999

ELITE II fails to confirm results of ELITE; Merck drops HF indication for Cozaar

Nov. 11, 1999

Clinical results for Enbrel in heart failure presented at AHA Scientific Sessions

Nov. 11, 1999

Heart Failure: Beyond Y2K -- a Prous Science webcast from the AHA

Nov. 11, 1999

News from AHA: photoangioplasty with Antrin is safe and effective for PAD

Nov. 11, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 20, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...